Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Estrogen Therapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07647328
What this trial is testing

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

Who this might be right for
ER-Positive HER2-Negative Breast Cancer
AstraZeneca 150
Not applicableStudy completedNCT03523195
What this trial is testing

Exercise Intervention After Cancer Treatment for Improving Health in Stage II-III Breast Cancer Survivors

Who this might be right for
Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage IIA Breast Cancer AJCC v8Anatomic Stage IIB Breast Cancer AJCC v8+16 more
Fred Hutchinson Cancer Center 20
Testing effectiveness (Phase 2)Study completedNCT00001181
What this trial is testing

Testolactone for the Treatment of Girls With LHRH Resistant Precocious Puberty

Who this might be right for
Polyostotic Fibrous DysplasiaPrecocious Puberty
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 100
Not applicableStudy completedNCT03719495
What this trial is testing

Evaluation of Endocrine Therapy Effects of Host Immunity in Early Stage Breast Cancer

Who this might be right for
Breast CancerEstrogen Receptor-positive Breast CancerHealthy
Duke University 68
Not applicableEnded earlyNCT04639661
What this trial is testing

Predictors of Periodontal Outcomes Post-sanative Therapy

Who this might be right for
Periodontal DiseasesPeriodontal Pocket
Brock University 12
Testing effectiveness (Phase 2)Active Not RecruitingNCT04567420
What this trial is testing

DNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)

Who this might be right for
Breast Cancer
Criterium, Inc. 70
Testing effectiveness (Phase 2)Study completedNCT00632723
What this trial is testing

IRESSA™ (Gefitinib) in Breast Cancer Patients

Who this might be right for
Breast Cancer
AstraZeneca 54
Testing effectiveness (Phase 2)Ended earlyNCT00379197
What this trial is testing

Phase II of Naltrexone in Hormone-Refractory Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Masonic Cancer Center, University of Minnesota 13
Testing effectiveness (Phase 2)Study completedNCT03844685
What this trial is testing

Red Clover and Lifestyle Changes to Contrast Menopausal Symptoms in Premenopausal Breast Cancer Patients Given Tamoxifen

Who this might be right for
Breast Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 88
Not applicableWithdrawnNCT01159236
What this trial is testing

Molecular Triaging of Newly Diagnosed Breast Cancer

Who this might be right for
Breast Cancer
M.D. Anderson Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00240071
What this trial is testing

Study of Avastin (Bevacizumab) to Reverse Acquired Estrogen Independence in Previously Hormone Responsive Metastatic Breast Ca.

Who this might be right for
Metastatic Breast Cancer
University of Alabama at Birmingham 30
Not applicableStudy completedNCT00463489
What this trial is testing

Lifestyle Intervention Study in Adjuvant Treatment of Early Breast Cancer

Who this might be right for
Breast Cancer
Ontario Clinical Oncology Group (OCOG) 338
Testing effectiveness (Phase 2)Looking for participantsNCT05868226
What this trial is testing

PRE-ISPY Phase I/II Oncology Platform Program

Who this might be right for
HER2-positive Breast CancerMetastatic CancerMetastatic Breast Cancer+29 more
QuantumLeap Healthcare Collaborative 280
Not applicableLooking for participantsNCT07015476
What this trial is testing

Retrospective Observational Evaluation of the Bone Mineral Density Outcome in Young Women With Amenorrhea

Who this might be right for
Amenorrhea
IRCCS Azienda Ospedaliero-Universitaria di Bologna 180
Testing effectiveness (Phase 2)Active Not RecruitingNCT01984138
What this trial is testing

REVIVE: Replens Versus Intra-Vaginal Estrogen for the Treatment of Vaginal Dryness on Aromatase Inhibitor Therapy

Who this might be right for
Estrogen Receptor Positive Breast CancerBreast Cancer
Polly A. Niravath, MD 33
Post-approval studies (Phase 4)Study completedNCT01778985
What this trial is testing

Effect of Preoperative Estrogen Treatment on Connective Tissues of the Pelvic Floor

Who this might be right for
Pelvic Organ ProlapseMenopause
University of Texas Southwestern Medical Center 30
Large-scale testing (Phase 3)Study completedNCT01573442
What this trial is testing

Testosterone in Treating Postmenopausal Patients With Arthralgia Caused by Adjuvant Aromatase Inhibitor Treatment

Who this might be right for
ArthralgiaBreast CancerHot Flashes+2 more
Alliance for Clinical Trials in Oncology 227
Not applicableEnded earlyNCT01648751
What this trial is testing

Vaginal Estrogen and Pelvic Floor Physical Therapy in Women With Symptomatic Mild Prolapse

Who this might be right for
Pelvic Organ Prolapse
Pamela Moalli 21
Post-approval studies (Phase 4)UnknownNCT02089854
What this trial is testing

Adjuvant Endocrine Therapy for Estrogen Receptor-beta Positive Triple Negative Breast Cancer

Who this might be right for
Female Breast Cancer
Peking Union Medical College Hospital 800
Large-scale testing (Phase 3)Study completedNCT00288002
What this trial is testing

Combination Chemotherapy With or Without Capecitabine and/or Trastuzumab Before Surgery in Treating Women With Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
GBG Forschungs GmbH 1,500
Next Page